Changzhou Comwin Fine Chemicals Co., Ltd.
|
Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment). In children, it is used with chemotherapy as the first treatment after the disease is diagnosed. |
Send Inquiry
|